Clinical trial
Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating…
NCT00354679 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00354679 |
|---|---|
| Title | Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer |
| Official title | Phase II Trial of Irinotecan, Cisplatin, Bevacizumab and Concurrent Radiotherapy in Locally Advanced Esophageal Adenocarcinoma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Biological, Drug, Genetic, Other, Procedure, Radiation |
| Interventions | bevacizumab, cisplatin, irinotecan hydrochloride, proteomic profiling, diagnostic laboratory biomarker analysis, mass spectrometry, adjuvant therapy, neoadjuvant therapy, therapeutic conventional surgery, radiation therapy |
| Enrollment | 34 |
| Start date | Apr 1, 2006 |
| Primary completion | Jun 1, 2015 |
| Completion | Jun 1, 2015 |
| First posted | Jul 20, 2006 |
| Last update posted | May 16, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: